Eva Costa Arpín

Neurodegenerative Disease ManagementAhead of Print Drug Evaluation Eva Costa Arpín *Author for correspondence: E-mail Address: costaarpin@yahoo.es https://orcid.org/0000-0003-3499-0383 Hospital Clínico Universitario, Travesía da Choupana s/n, 15706, Santiago de Compostela, A Coruña, Spain Abstract Fampridine is the only drug approved for the treatment of walking impairment in multiple sclerosis.

Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Email: If the address matches an existing account you will receive an email with instructions to retrieve your username